[Treatment guidelines for age-related macular degeneration].

Kanji Takahashi, Yuichiro Ogura, Tatsuro Ishibashi, Fumio Shiraga, Mitsuko Yuzawa

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We describe treatment guidelines for age-related macular degeneration (AMD) in Japan in line with the accepted classification and diagnostic criteria of AMD in Japan. A working group of five members drew up an AMD treatment algorithm based on a comprehensive review of foreign guidelines and recent data gathered in Japan. We applied lifestyle and dietary modifications and anti-oxidative supplementation to the prodromal stage of AMD and atrophic AMD. We recommend that, depending on the type of disease (typical AMD, polypoidal choroidal vasculopathy, or retinal angiomatous proliferation), an anti-vascular endothelial growth factor drug,

Original languageEnglish
Pages (from-to)1150-1155
Number of pages6
JournalJournal of Japanese Ophthalmological Society
Volume116
Issue number12
Publication statusPublished - Dec 2012
Externally publishedYes

Fingerprint

Macular Degeneration
Guidelines
Japan
Therapeutics
Prodromal Symptoms
Diet Therapy
Vascular Endothelial Growth Factor A
Life Style
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Takahashi, K., Ogura, Y., Ishibashi, T., Shiraga, F., & Yuzawa, M. (2012). [Treatment guidelines for age-related macular degeneration]. Journal of Japanese Ophthalmological Society, 116(12), 1150-1155.

[Treatment guidelines for age-related macular degeneration]. / Takahashi, Kanji; Ogura, Yuichiro; Ishibashi, Tatsuro; Shiraga, Fumio; Yuzawa, Mitsuko.

In: Journal of Japanese Ophthalmological Society, Vol. 116, No. 12, 12.2012, p. 1150-1155.

Research output: Contribution to journalArticle

Takahashi, K, Ogura, Y, Ishibashi, T, Shiraga, F & Yuzawa, M 2012, '[Treatment guidelines for age-related macular degeneration].', Journal of Japanese Ophthalmological Society, vol. 116, no. 12, pp. 1150-1155.
Takahashi, Kanji ; Ogura, Yuichiro ; Ishibashi, Tatsuro ; Shiraga, Fumio ; Yuzawa, Mitsuko. / [Treatment guidelines for age-related macular degeneration]. In: Journal of Japanese Ophthalmological Society. 2012 ; Vol. 116, No. 12. pp. 1150-1155.
@article{248054ebc120490b89f49b8a7c8db672,
title = "[Treatment guidelines for age-related macular degeneration].",
abstract = "We describe treatment guidelines for age-related macular degeneration (AMD) in Japan in line with the accepted classification and diagnostic criteria of AMD in Japan. A working group of five members drew up an AMD treatment algorithm based on a comprehensive review of foreign guidelines and recent data gathered in Japan. We applied lifestyle and dietary modifications and anti-oxidative supplementation to the prodromal stage of AMD and atrophic AMD. We recommend that, depending on the type of disease (typical AMD, polypoidal choroidal vasculopathy, or retinal angiomatous proliferation), an anti-vascular endothelial growth factor drug,",
author = "Kanji Takahashi and Yuichiro Ogura and Tatsuro Ishibashi and Fumio Shiraga and Mitsuko Yuzawa",
year = "2012",
month = "12",
language = "English",
volume = "116",
pages = "1150--1155",
journal = "Journal of Japanese Ophthalmological Society",
issn = "0029-0203",
publisher = "Nippon Ganka Gakkai",
number = "12",

}

TY - JOUR

T1 - [Treatment guidelines for age-related macular degeneration].

AU - Takahashi, Kanji

AU - Ogura, Yuichiro

AU - Ishibashi, Tatsuro

AU - Shiraga, Fumio

AU - Yuzawa, Mitsuko

PY - 2012/12

Y1 - 2012/12

N2 - We describe treatment guidelines for age-related macular degeneration (AMD) in Japan in line with the accepted classification and diagnostic criteria of AMD in Japan. A working group of five members drew up an AMD treatment algorithm based on a comprehensive review of foreign guidelines and recent data gathered in Japan. We applied lifestyle and dietary modifications and anti-oxidative supplementation to the prodromal stage of AMD and atrophic AMD. We recommend that, depending on the type of disease (typical AMD, polypoidal choroidal vasculopathy, or retinal angiomatous proliferation), an anti-vascular endothelial growth factor drug,

AB - We describe treatment guidelines for age-related macular degeneration (AMD) in Japan in line with the accepted classification and diagnostic criteria of AMD in Japan. A working group of five members drew up an AMD treatment algorithm based on a comprehensive review of foreign guidelines and recent data gathered in Japan. We applied lifestyle and dietary modifications and anti-oxidative supplementation to the prodromal stage of AMD and atrophic AMD. We recommend that, depending on the type of disease (typical AMD, polypoidal choroidal vasculopathy, or retinal angiomatous proliferation), an anti-vascular endothelial growth factor drug,

UR - http://www.scopus.com/inward/record.url?scp=84887201224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887201224&partnerID=8YFLogxK

M3 - Article

C2 - 23379205

AN - SCOPUS:84887201224

VL - 116

SP - 1150

EP - 1155

JO - Journal of Japanese Ophthalmological Society

JF - Journal of Japanese Ophthalmological Society

SN - 0029-0203

IS - 12

ER -